BGI SENTIS™ Comprehensive Hereditary Cancer Panel
BGI’s hereditary risk screening cancer panels target genes previously linked to a predisposition of cancer. Panel selection was based on expert curation of scientific literature and other high quality resources, including formal medical guidelines.
BGI’s Comprehensive Hereditary Cancer Panels provides information on 79 genes associated with 24 different types of hereditary cancer including some of the most commonly occurring cancers such as hereditary breast, ovarian, colorectal, pancreatic, prostate, and stomach cancer. BGI detects different alterations including germline SNV, Indels, and CNV.
华大基因的遗传风险筛查癌症小组以先前与癌症易感性相关的基因为目标。专家小组的选择是基于专家对科学文献和其他高质量资源的管理，包括正式的医学指南。华大基因研究所的综合遗传癌症研究小组提供了与24种不同类型的遗传癌症相关的79个基因的信息，包括一些最常见的癌症，如遗传性乳腺癌、卵巢癌、结肠直肠癌、胰腺癌、前列腺癌和胃癌。华大基因检测到不同的变异，包括生殖系 SNV、 Indels 和 CNV。
Patients suspected of being at increased risk of hereditary cancer
14 - 26 days
Peripheral blood, DNA, Saliva
Target region capture, High-throughput sequencing
Ordering the BGI SENTIS™ Hereditary Cancer Screening is easy.
Physician orders test
Blood or saliva sample collected
Sample shipped to BGI and analyzed
Results sent to physician